Stockscreener 앱 받기
4.92
4.84%
-0.25
시간 외 거래:
4.93
0.010
+0.20%
Recursion Pharmaceuticals Inc 주식(RXRX)의 최신 뉴스
Recursion Q1 2025 slides: AI platform advances pipeline amid earnings miss By Investing.com - Investing.com South Africa
Layoff Tracker: ADC Therapeutics Cutting 30% of Staff, Closing London Research Facility - BioSpace
Recursion Q1 2025 slides: AI platform advances pipeline amid earnings miss - Investing.com Australia
Insmed surges on lung drug data; Recursion cuts staff - Yahoo Finance
Why Skyrocketed Recursion Pharmaceuticals, Inc. (RXRX) Today - MSN
Recursion: Lack Of Near-Term Catalysts Leaves The Stock Vulnerable (NASDAQ:RXRX) - Seeking Alpha
Recursion Pharmaceuticals (RXRX) Jumps 31% On Next-Gen AI - MSN
Recursion to lay off 20% of workforce amid biotech funding woes - MSN
Why Recursion Pharmaceuticals Was Bouncing Higher on Tuesday - MSN
After pipeline cull, AI drug developer Recursion cuts staff by 20% - FirstWord Pharma
Recursion Pharma to reduce workforce by 20% - MSN
Recursion Eliminating 20% of Workforce, Citing Pipeline Pruning and Capital Markets - Genetic Engineering and Biotechnology News
Recursion Pharmaceuticals Stock Surges After Company Lays Off 20% Workforce: Retail Predicts ‘Blue Skies’ Ahead - MSN
Recursion Pharmaceuticals Stock Is Up 10% Today: What's Happening? - Benzinga
Recursion Downsizes by 20% To Boost Cash Position - BioSpace
Recursion lays off 20% of staff in wake of pipeline cutbacks - Fierce Biotech
Recursion Pharmaceuticals: Recent Readouts Disappointing, Future Readouts Risky (RXRX) - Seeking Alpha
Recursion to lay off 20% of workforce, narrows focus amid biotech downturn - 1470 & 100.3 WMBD
Recursion Cuts 20% of Workforce, Extends Cash Runway to Late 2027 - marketscreener.com
Recursion Pharma to reduce workforce by 20% (RXRX:NASDAQ) - Seeking Alpha
Recursion Pharmaceuticals Stock (RXRX): AI Breakthrough for Drug Development - Value The Markets
Recursion Pharmaceuticals (RXRX) Implements Workforce and Operat - GuruFocus
Recursion Pharmaceuticals Announces Workforce Reduction Strategy - TipRanks
Recursion Pharmaceuticals announces 20% workforce reduction - TipRanks
Recursion Pharmaceuticals Announces Personnel And Infrastructure ReductionSEC Filing - marketscreener.com
15 Stocks That Stole The Show Last Week - Insider Monkey
Recursion rises on launch of Boltz-2 in partnership with MIT - MSN
Why Recursion Pharmaceuticals (RXRX) Soared On Friday - Insider Monkey
10 Stocks Are Dominating Like Wall Street Titans - Insider Monkey
Recursion Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:RXRX - Benzinga
Recursion Announces First Patient Dosed in Phase 1 Clinical Study of REC-3565, a Selective MALT1 Inhibitor for Relapsed or Refractory B-cell Lymphomas - mx.advfn.com
Recursion Pharmaceuticals Stock Surges On Breakthrough AI Model Launch With MIT - Benzinga
Recursion Pharmaceuticals shares surge on AI model release By Investing.com - Investing.com South Africa
Recursion Pharmaceuticals shares surge on AI model release - Investing.com
Recursion Pharmaceuticals call volume above normal and directionally bullish - TipRanks
Recursion Pharmaceuticals (RXRX) Sees Surge in Bullish Options Activity | RXRX Stock News - GuruFocus
Recursion (RXRX) Shares Jump on New Biomolecular Model Launch - GuruFocus
MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy - The Globe and Mail
July 25th Options Now Available For Recursion Pharmaceuticals (RXRX) - Nasdaq
Recursion Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:RXRX) - Defense World
These 10 Stocks Are On Fire Right Now - Insider Monkey
AI in Healthcare Just Crossed a Tipping Point. Investors Are Watching These Names – Company Announcement - Financial Times
Recursion Pharmaceuticals (RXRX) Sees Surge in Bullish Options A - GuruFocus
Recursion Pharmaceuticals (RXRX) Up 5.7% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Ameriprise Financial Inc. Acquires 29,034 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World
Recursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Down 5.1% – Here’s What Happened - Defense World
Was Jim Cramer Right About Recursion Pharmaceuticals, Inc. (RXRX)? - MSN
Recursion to Participate in Upcoming Investor Conferences - Yahoo Finance
1.91%
1.17%
자본화:
|
볼륨(24시간):